Back to Search Start Over

Phenotypic effects of genetic variants associated with autism

Authors :
Rolland, Thomas
Cliquet, Freddy
Anney, Richard
Moreau, Clara
Traut, Nicolas
Mathieu, Alexandre
Huguet, Guillaume
Duan, Jinjie
Warrier, Varun
Portalier, Swan
Dry, Louise
Leblond, Claire
Douard, Elise
Amsellem, Frédérique
Malesys, Simon
Maruani, Anna
Toro, Roberto
Børglum, Anders D.
Grove, Jakob
Baron-Cohen, Simon
Packer, Alan
Chung, Wendy
Jacquemont, Sébastien
Delorme, Richard
Bourgeron, Thomas
Génétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions (GHFC (UMR_3571 / U-Pasteur_1))
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Cardiff University
Centre de Recherches Interdisciplinaires (CRI)
Université Paris Cité (UPCité)
Centre de recherche du CHU Sainte-Justine / Research Center of the Sainte-Justine University Hospital [Montreal, Canada]
Université de Montréal (UdeM)-CHU Sainte Justine [Montréal]
The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)
Aarhus University [Aarhus]
Center for Genomics and Personalized Medicine [Aarhus, Denmark] (CGPM)
University of Cambridge [UK] (CAM)
Université de Montréal (UdeM)
Service psychiatrique de l'enfant et de l'adolescent [CHU Hôpital Robert Debré]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré
Simons Foundation
Columbia University Medical Center (CUMC)
Columbia University [New York]
S.J. is supported by Calcul Quebec and Compute Canada, NIH U01 grant for CAMP (1U01MH119690–01), the Canadian Institutes of Health Research, CIHR_400528, and the Institute of Data Valorization (IVADO) through the Canada First Research Excellence Fund. S.J. is a recipient of a Canada Research Chair in neurodevelopmental disorders and a chair from the Jeanne et Jean Louis Levesque Foundation. This work was funded by Institut Pasteur, the Bettencourt-Schueller Foundation, Université de Paris, the Conny-Maeva Charitable Foundation, the Cognacq Jay Foundation, the Eranet-Neuron (ALTRUISM) and the GenMed Labex, AIMS-2-TRIALS, which received support from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777394 and the Inception program (Investissement d’Avenir grant ANR-16-CONV-0005). This project has received funding from the Horizon Europe programs CANDY and R2D2-MH under grant agreement nos. 847818 and 101057385. Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. Additionally, for UK partners, the work was funded by UK Research and Innovation under the UK government’s Horizon Europe funding guarantee (grant no.10039383). The iPSYCH team was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724 and R248-2017-2003) and the Universities and University Hospitals of Aarhus and Copenhagen. High-performance computer capacity for handling and statistical analysis of iPSYCH data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to A.D.B.). S.B.C. received funding from the Wellcome Trust 214322\Z\18\Z, support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. S.B.C. also received funding from the Autism Centre of Excellence, SFARI, the Templeton World Charitable Fund, the Medical Research Council and the National Institute for Health Research Cambridge Biomedical Research Centre. The research was supported by the National Institute for Health Research Applied Research Collaboration East of England.
ANR-16-CONV-0005,INCEPTION,Institut Convergences pour l'étude de l'Emergence des Pathologies au Travers des Individus et des populatiONs(2016)
European Project: 777394,H2020-JTI-IMI2-2016-10-two-stage,AIMS-2-TRIALS(2018)
Source :
Nature Medicine, Nature Medicine, 2023, ⟨10.1038/s41591-023-02408-2⟩
Publication Year :
2023
Publisher :
HAL CCSD, 2023.

Abstract

International audience; While over 100 genes have been associated with autism, little is known about the prevalence of variants affecting them in individuals without a diagnosis of autism. Nor do we fully appreciate the phenotypic diversity beyond the formal autism diagnosis. Based on data from more than 13,000 individuals with autism and 210,000 undiagnosed individuals, we estimated the odds ratios for autism associated to rare loss-of-function (LoF) variants in 185 genes associated with autism, alongside 2,492 genes displaying intolerance to LoF variants. In contrast to autism-centric approaches, we investigated the correlates of these variants in individuals without a diagnosis of autism. We show that these variants are associated with a small but significant decrease in fluid intelligence, qualification level and income and an increase in metrics related to material deprivation. These effects were larger for autism-associated genes than in other LoF-intolerant genes. Using brain imaging data from 21,040 individuals from the UK Biobank, we could not detect significant differences in the overall brain anatomy between LoF carriers and non-carriers. Our results highlight the importance of studying the effect of the genetic variants beyond categorical diagnosis and the need for more research to understand the association between these variants and sociodemographic factors, to best support individuals carrying these variants.

Details

Language :
English
ISSN :
10788956 and 17447933
Database :
OpenAIRE
Journal :
Nature Medicine, Nature Medicine, 2023, ⟨10.1038/s41591-023-02408-2⟩
Accession number :
edsair.dedup.wf.001..b211d9335f2e7abc6d08135cbe9e3291
Full Text :
https://doi.org/10.1038/s41591-023-02408-2⟩